Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 813 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR EMA Recommends Extension of Indications for Tislelizumab to First-Line Treatment of... November 19, 2024 Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and... June 3, 2025 ΤΙ ΕΙΝΑΙ January 18, 2019 Personalised blood test could help predict which lung cancers might return April 1, 2022 Load more HOT NEWS Cancer Patients Get Free, Beautiful Henna Crowns From Local Artist Cancer Research UK’s Race for Life celebrates its 30th year by... Your Microbiome and Cancer: What to Know FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer
